Literature DB >> 17885730

Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.

D Müller1, T D Szucs.   

Abstract

INTRODUCTION: Influenza continues to be a considerable health problem in Europe. Vaccination is the only preventive measure, reducing mortality and morbidity of influenza in all age groups
OBJECTIVES: The objective of this survey was to assess and compare the level of influenza vaccination coverage during three consecutive influenza seasons (02/03, 03/04, 04/05) in the five European countries United Kingdom, France, Italy, Germany and Spain, understand the driving forces and barriers to vaccination now and 3 years ago and determine vaccination intentions for the following winter.
METHODS: We conducted a random-sampling, telephone-based household survey among non-institutionalized individuals representative of the population aged 14 and over. The surveys used the same questionnaire for all three seasons. The data were subsequently pooled. Four target groups were determined for analysis: (1) persons aged 65 and over; (2) people working in the medical field; (3) persons suffering from chronic illness and (4) a group composed of persons aged 65 and over or working in the medical field or suffering from a chronic illness.
RESULTS: The overall sample consisted of 28,021 people. The influenza vaccination coverage rate increased from 21.0% in season 02/03 to 23.6% in season 03/04 and then to 23.7% in season 04/05. The differences between the seasons are statistically significant (p = 0.01). The highest rate over all countries and seasons had Germany in season 04/05 with 26.5%, Spain had in season 02/03 with 19.3% the lowest rate totally. The coverage rate in the target group composed of person's aged 65 and over or working in the medical field or suffering from a chronic illness was 49.7% in season 02-04 and 50.0% in season 04/05. The driving forces and barriers to vaccination did not change over the years. The most frequent reasons for being vaccinated given by vaccines were: influenza, considered to be a serious illness which people wanted to avoid, having received advise from the family doctor or nurse to be vaccinated and not wanting to infect family and friends. Reasons for not being vaccinated mentioned by people who have never been vaccinated were: not expecting to catch influenza, not having considered vaccination before and not having received a recommendation from the family doctor to be vaccinated. Options encouraging influenza vaccination are: recommendation by the family doctor or nurse, more available information on the vaccine regarding efficacy and tolerance and more information available about the disease. The adjusted odds ratio of receiving influenza vaccine varied between 2.5 in Germany and 6.3 in the United Kingdom in any risk group.
CONCLUSION: The vaccination coverage rate increased from the first season (21.0%) to the third season (23.7%) by 2.6%. The family doctor is the most important source of encouragement for people to be vaccinated against influenza. It seems that the public would be more likely to be vaccinated if they had more information on the efficacy and tolerance of the vaccine, as well as the disease. We therefore suggest that family doctors be better informed on influenza vaccine and the disease itself, so that they can actively inform their patients on these topics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885730     DOI: 10.1007/s15010-007-6218-5

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  24 in total

1.  Influenza moves to the front of public health concerns.

Authors:  C Ruef
Journal:  Infection       Date:  2009-06       Impact factor: 3.553

2.  Influenza vaccination coverage among high-risk groups in 11 European countries.

Authors:  Adrian Loerbroks; Christian Stock; Jos A Bosch; David G Litaker; Christian J Apfelbacher
Journal:  Eur J Public Health       Date:  2011-07-12       Impact factor: 3.367

3.  Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability.

Authors:  Filippo Ansaldi; Andrea Orsi; Daniela de Florentiis; Valentina Parodi; Emanuela Rappazzo; Martina Coppelli; Paolo Durando; Giancarlo Icardi
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

Review 4.  Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age.

Authors:  Isabel Leroux-Roels; Françoise Weber
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

Review 5.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2014-07-07

6.  ADHERENCE TO INFLUENZA VACCINATION AMONG MEDICAL STUDENTS DURING AND AFTER INFLUENZA A (H1N1) PANDEMIC.

Authors:  Stéfano Ivani de Paula; Gustavo Ivani de Paula; Kelly Simone Almeida Cunegundes; Maria Isabel de Moraes-Pinto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-11-03       Impact factor: 1.846

Review 7.  Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data.

Authors:  Jason M Nagata; Isabel Hernández-Ramos; Anand Sivasankara Kurup; Daniel Albrecht; Claudia Vivas-Torrealba; Carlos Franco-Paredes
Journal:  BMC Public Health       Date:  2013-04-25       Impact factor: 3.295

8.  Erratic flu vaccination emerges from short-sighted behavior in contact networks.

Authors:  Daniel M Cornforth; Timothy C Reluga; Eunha Shim; Chris T Bauch; Alison P Galvani; Lauren Ancel Meyers
Journal:  PLoS Comput Biol       Date:  2011-01-27       Impact factor: 4.475

9.  Barriers Associated with the Uptake Ratio of Seasonal Flu Vaccine and Ways to Improve Influenza Vaccination Coverage among Young Health Care Workers in Poland.

Authors:  Sylwia Kałucka; Izabela Grzegorczyk-Karolak
Journal:  Vaccines (Basel)       Date:  2021-05-20

10.  Outpatient-based pneumococcal vaccine campaign and survey of perceptions about pneumococcal vaccination in patients and doctors.

Authors:  Joon Young Song; Hee Jin Cheong; Jung Yeon Heo; Ji Yun Noh; Yu Bin Seo; In Seon Kim; Won Suk Choi; Woo Joo Kim
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.